Serum BMP-2 Up-regulation as an Indicator of Poor Survival in Advanced Non-small Cell Lung Cancer Patients |
Fei, Zheng-Hua
(The Second Clinical College, Zhejiang Chinese Medical University)
Yao, Cheng-Yun (Department of Radiotherapy, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) Yang, Xiao-Lei (Department of Rehabilitation Oncology, the First Affiliated Hospital of Wenzhou Medical University) Huang, Xin-En (Department of Chemotherapy, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) Ma, Sheng-Lin (The Second Clinical College, Zhejiang Chinese Medical University) |
1 | Choi YJ, Kim ST, Park KH (2012). The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients. Med Oncol, 29, 582-8. DOI ScienceOn |
2 | Arrieta Rodriguez OG, Villarreal-Garza C, Mart nez-Barrera L, et al (2013). Usefulness of serum carcinoembryonic antigen (cea) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: A prospective cohort study. BMC Cancer, 13, 254. DOI ScienceOn |
3 | Bieniasz M, Oszajca K, Eusebio M, et al (2009). The positive correlation between gene expression of the two angiogenic factors: Vegf and bmp-2 in lung cancer patients. Lung Cancer, 66, 319-26. DOI ScienceOn |
4 | Chen A, Wang D, Liu X, et al (2012). Inhibitory effect of bmp- 2 on the proliferation of breast cancer cells. Mol Med Rep, 6, 615-20. DOI |
5 | Dai J, Hall CL, Escara-Wilke J, et al (2008). Prostate cancer induces bone metastasis through wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res, 68, 5785-94. DOI ScienceOn |
6 | Deng H, Ravikumar TS, Yang WL (2009). Overexpression of bone morphogenetic protein 4 enhances the invasiveness of smad4-deficient human colorectal cancer cells. Cancer Lett, 281, 220-31. DOI ScienceOn |
7 | Deng QQ, Huang XE, Ye LH, et al (2013). Phase II trial of Loubo (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes. Asian Pac J Cancer Prev, 14, 413-7. DOI ScienceOn |
8 | Dzietczenia J, Wrobel T, Jazwiec B, et al (2010). Expression of bone morphogenetic proteins (bmps) receptors in patients with b-cell chronic lymphocytic leukemia (b-cll). Int J Lab Hematol, 32, e217-21. DOI ScienceOn |
9 | Gao LL, Huang XE, Zhang Q, et al (2011). A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial. Asian Pac J Cancer Prev, 12, 77-80. |
10 | Gong P, Huang XE, Chen CY, et al (2012). Comparison on complications of peripherally inserted central catheters by ultrasound guide or conventional method in cancer patients. Asian Pac J Cancer Prev, 13, 873-5. DOI ScienceOn |
11 | Gu M, Li SY, Huang XE, et al (2013). A phase II study on continuous infusional paclitaxel and 5-Fu as first-line chemotherapy for patients with advanced esophageal cancer. Asian Pac J Cancer Prev, 13, 5587-91. DOI ScienceOn |
12 | Hsu YL, Huang MS, Yang CJ, et al (2011). Lung tumorassociated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by runx2/snail signaling pathway. J Biol Chem, 286, 37335-46. DOI ScienceOn |
13 | Hocking JC, McFarlane S (2007). Expression of bmp ligands and receptors in the developing xenopus retina. Int J Dev Biol, 51, 161-5. DOI ScienceOn |
14 | Hogan BL (1996). Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev, 10, 1580-94. DOI ScienceOn |
15 | Hsu PS, Wang YS, Huang SC, et al (2011). Improving detection accuracy of lung cancer serum proteomic profiling via twostage training process. Proteome Sci, 9, 20. DOI ScienceOn |
16 | Huang XE, Li CG, Li Y, et al (2011). Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a phase II trial. Asian Pac J Cancer Prev, 12, 2797-2800. |
17 | Huang XE, Wei GL, Huo JG, et al (2013). Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites. Asian Pac J Cancer Prev, 14, 2611-4. DOI ScienceOn |
18 | Langenfeld EM, Kong Y, Langenfeld J (2006). Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of smad-1/5. Oncogene, 25, 685-92. DOI ScienceOn |
19 | Jiang Y, Huang XE, Yan PW, et al (2010). Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 11, 1059-62. |
20 | Jones M, Dobson A, O'Brian S (2011). A graphical method for assessing agreement with the mean between multiple observers using continuous measures. Int J Epidemiol, 40, 1308-13. DOI ScienceOn |
21 | Li CG, Huang XE,Li Y, et al (2011). Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pac J Cancer Prev, 12, 487-90. |
22 | Katsuno Y, Hanyu A, Kanda H (2008). Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through smad pathway. Oncogene, 27, 6322-33. DOI ScienceOn |
23 | Li CG, Huang XE, Li Y, et al (2011). Clinical observations on safety and efficacy of OxyContin administered by rectal route in treating cancer related pain. Asian Pac J Cancer Prev, 12, 2477-8. |
24 | Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 301-4. 과학기술학회마을 DOI ScienceOn |
25 | Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 12, 2405-09. |
26 | Liu C, Tian G, Tu Y, et al (2009). Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas. Jpn J Clin Oncol, 39, 625-31. DOI ScienceOn |
27 | Lu YY, Huang XE, Xu L, et al (2013). Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs. Asian Pac J Cancer Prev, 14, 2005-8. DOI ScienceOn |
28 | Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from rosa roxburghii tratt and fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14. DOI ScienceOn |
29 | Ma Y, Ma L, Guo Q, et al (2010). Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res, 29, 85. DOI ScienceOn |
30 | Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5. DOI ScienceOn |
31 | Miyazono K (2002). A new partner for inhibitory smads. Cytokine Growth Factor Rev, 13, 7-9. DOI ScienceOn |
32 | Ohe Y, Ohashi Y, Kubota K, et al (2007). Randomized phase iii study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Fourarm cooperative study in japan. Ann Oncol, 18, 317-23. |
33 | Park Y, Kim JW, Kim DS, et al (2008). The bone morphogenesis protein-2 (bmp-2) is associated with progression to metastatic disease in gastric cancer. Cancer Res Treat, 40, 127-32. DOI ScienceOn |
34 | Shen Z, Kauttu T, Cao J, et al (2013). Macrophage coculture enhanced invasion of gastric cancer cells via tgf-beta and bmp pathways. Scand J Gastroenterol, 48, 466-72. DOI ScienceOn |
35 | Qian Q, Zhan P, Yu L, et al (2011). Baseline levels and decrease in serum soluble intercellular adhesion molecule-1 during chemotherapy predict objective response and survival in patients who have advanced non-small-cell lung cancer. Clin Lung Cancer, 12, 131-7. DOI ScienceOn |
36 | Reich JM. (2005). Lung-cancer screening. N Engl J Med, 353, 2194-5. DOI ScienceOn |
37 | Sun MQ, Meng AF, Huang XE, et al (2013). Comparison of psychological influence on breast cancer patients between breast-conserving surgery and modified radical mastectomy. Asian Pac J Cancer Prev, 14, 149-52. DOI ScienceOn |
38 | Rothhammer T, Poser I, Soncin F, et al (2005). Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res, 65, 448-56. |
39 | Shu J, Li CG, Liu YC, et al (2012).Comparison of Serum Tumor Associated Material (TAM) with Conventional Biomarkers in Cancer Patients. Asian Pac J Cancer Prev, 13, 2399-403. DOI ScienceOn |
40 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
41 | Wu XY, Huang XE, You SX, et al (2013). Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer. Asian Pac J Cancer Prev, 14, 2019-22. DOI ScienceOn |
42 | Xu HX, Huang XE, Li Y, et al (2011). A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer Prev, 12, 2233-6. |
43 | Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of Endostar combined with chemotherapy in advanced colorectal cancer patients. Asian Pac J Cancer Prev, 12, 3087-90. |
44 | Yan PW, Huang XE, Jiang Y, et al (2010). A clinical comparison on safety and efficacy of Paclitaxel/Epirubicin (NE) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer. Asian Pac J Cancer Prev, 11, 1115-8. |
45 | Xu JW, Li CG, Huang XE, et al (2011). Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced lung adenocarcinoma cases. Asian Pac J Cancer Prev, 12, 985-7. |
46 | Yilmaz M, Christofori G (2009). Emt, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev, 28, 15-33. DOI |
47 | Xu T, Xu ZC, Zou Q, Yu B, Huang XE (2012). P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians. Asian Pac J Cancer Prev, 13, 2349-54. DOI ScienceOn |
48 |
Xu X, Wang L, Xu HQ, Huang XE, et al (2013). Clinical comparison between paclitaxel liposome (Lipusu |
49 | Yan PW, Huang XE, Yan F, et al (2011). Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. Asian Pac J Cancer Prev, 12, 2291-4. |
50 | Yin HT, Tian QZ, Guan L,n vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev, 14, 1703-6. 과학기술학회마을 DOI ScienceOn |
51 | Yin HT, Zhang DG, Wu XL, Huang XE, Chen G (2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12. 과학기술학회마을 DOI ScienceOn |
52 | Zhan YP, Huang XE, Cao J, Clinical study on safety and efficacy of Qinin (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev, 13, 4773-6. |
53 | Yu DH, Li JH, Wang YC, et al (2011). Serum anti-p53 antibody detection in carcinomas and the predictive values of serum p53 antibodies, carcino-embryonic antigen and carbohydrate antigen 12-5 in the neoadjuvant chemotherapy treatment for iii stage non-small cell lung cancer patients. Clin Chim Acta, 412, 930-5. DOI ScienceOn |
54 | Zhang LQ, Huang XE, Wang J (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a metaanalysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5. |
55 | Yu DS, Huang XE, Zhou JN, et al (2012). Comparative study on the value of anal preserving surgery for aged people with low rectal carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, 13, 2339-40. DOI ScienceOn |
56 | Yu Y, Yang JL, Chapman-Sheath PJ, et al (2002). Tgf-beta, bmps, and their signal transducing mediators, smads, in rat fracture healing. J Biomed Mater Res, 60, 392-7. DOI ScienceOn |
57 | Zhan YP, Huang XE, Cao J (2012). Clinical safety and efficacy of Kanglaite (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev, 13, 5319-21. DOI ScienceOn |
58 | Zhang XZ, Huang XE, Xu YL, et al (2012). A Phase II Study on Voriconazole in Treating Chinese Patients with Malignant Hematological Disorder and Invasive Aspergillosis. Asian Pac J Cancer Prev, 13, 2415-8. DOI ScienceOn |
59 | Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/ Docetaxel combined with a paltinum in the treatment of advanced non-samll cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50. |
60 |
Liu J, Huang XE, Tian GY, et al (2013). Phase II study on safety and efficacy of Yadanzi |
61 | Zhang N, Ye L, Wu L, et al (2013). Expression of bone morphogenetic protein-10 (bmp10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro. Anticancer Res, 33, 1917-25. |
![]() |